Targeted Molecular Therapy
4 clinical trials · Condition
◉ Watch Targeted Molecular Therapy
| Record | Firm | Date |
|---|---|---|
| a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors (NCT05177666) | The University of Hong Kong-Shenzhen Hospital | 2021-12-30 |
| Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer. (NCT04720131) | Beijing Friendship Hospital | 2021-01-01 |
| A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment (NCT02688491) | First Affiliated Hospital, Sun Yat-Sen University | 2016-07-01 |
| Association of Psychological Distress in Patients With Lung Cancer (NCT06218901) | Shanghai Chest Hospital | 2016-01-01 |
Track Targeted Molecular Therapy automatically
Every clearance here is in the API, with alerts when new ones post.